Tandem Diabetes Care
TNDM
88 hedge funds and large institutions have $210M invested in Tandem Diabetes Care in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 13 reducing their positions, and 17 closing their positions.
246% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 13
2% less funds holding
Funds holding: 90 → 88 (-2)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
12% less capital invested
Capital invested by funds: $238M → $210M (-$28.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.64M |
| 2 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$3.88M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$3.78M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$3.15M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$3.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$6.09M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$5.9M |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$4.1M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.74M |
TNDM Hedge Fund Activity: Q2 2015 in Review
88 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2015, worth a combined $210M — down 12% from $238M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of TNDM and 15 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 45 added.
The largest buyer was Point72 Asset Management, adding an estimated $9.64M. The largest seller was Fidelity Investments, exiting entirely with an estimated $8.2M sold.
- 88 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2015, down from 90 in Q1 2015.
- Funds reported $210M of Tandem Diabetes Care stock for Q2 2015, down 12% quarter-over-quarter.
- 15 funds opened new Tandem Diabetes Care positions in Q2 2015 and 17 closed out, a net change of -2 holders.
- The largest Tandem Diabetes Care buyer in Q2 2015 was Point72 Asset Management, an estimated $9.64M added.
- The largest Tandem Diabetes Care seller in Q2 2015 was Fidelity Investments, an estimated $8.2M sold.
Based on aggregated 13F filings for Q2 2015.